This intricate investigation started by manipulating GLIS3 expression in primary fibroblasts through CRISPR knockout (CRISPRko) and activation (CRISPRa) approaches, subsequently stimulating these cells with pro-fibrotic cytokines TGFβ and IL-1β. Transcriptomic analyses revealed over 150 genes exhibiting decreased expression upon GLIS3 disruption but were conversely induced with GLIS3 activation. Significantly, these GLIS3 effector genes include IL11, a cytokine implicated in fibroblast-driven tissue damage, along with LIF and FAP, markers tied to fibroblast activation and intestinal stricture development respectively.

Further transcriptional targets identified comprise MMP2, an enzyme facilitating monocyte infiltration into damaged tissues, directly linking GLIS3 activity to macrophage-fibroblast cross-talk mechanisms. Other GLIS3-regulated genes such as PTGFR and SERPINE1 contribute to epithelial regeneration and mucosal injury processes in colitis, indicating a broad regulatory network modulated by GLIS3 that transcends mere fibrotic signaling.

To verify direct DNA binding targets of GLIS3, researchers conducted chromatin immunoprecipitation sequencing (ChIP-seq) using fibroblasts engineered to express GLIS3 tagged with a 3xFlag epitope. This approach identified 1,291 GLIS3-bound genomic loci, with a notable fraction enriched near transcription start sites and intragenic regulatory regions. Importantly, GLIS3 occupancy was enhanced upon stimulation, suggesting dynamic control of key genes involved in extracellular matrix organization and inflammatory responses.

Among direct GLIS3 targets is IL11, with binding peaks mapped upstream of its transcription start site. Motif enrichment analysis of GLIS3-bound regions uncovered co-enrichment of binding sites for transcription factors FOSL1 — a member of the AP-1 complex known to regulate IL-11 in other disease contexts — and TEAD family members, which act downstream of the YAP/TAZ mechanotransduction pathway implicated in fibrosis. These findings imply a cooperative transcriptional network wherein GLIS3 facilitates recruitment or stabilization of additional regulators critical for fibrotic gene expression.

Functional follow-up experiments using chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR) demonstrated that GLIS3 absence impairs the binding of both FOSL1 and TEAD1 to their respective target genes, corroborating its role as a master regulator of this fibrotic gene network. Interestingly, IL11 expression was uniquely dependent on GLIS3 and TEAD1/TEAD3, highlighting distinct regulatory mechanisms at this key cytokine locus.

Given these insights from in vitro experiments, the team formulated a GLIS3 gene signature comprising effector genes bound and regulated by GLIS3, tightly associated with the IAF phenotype. This signature was then projected onto transcriptomic data from the well-characterized PROTECT cohort, comprising treatment-naive pediatric UC patients. Remarkably, GLIS3 signature enrichment correlated positively with disease severity scores (Mayo score), and further analyses refined a 50-gene subset predictive of clinical status.

Integrative cellular deconvolution of bulk RNA sequencing data from patient biopsies revealed that increasing disease severity was accompanied by elevated proportions of IAFs and activated macrophages within the colon. Both cell types showed strong correlations with the GLIS3 gene signature, underscoring the centrality of a GLIS3-driven fibrotic and inflammatory circuit in the pathogenesis of UC.

Altogether, this comprehensive body of work illuminates GLIS3 as a master transcriptional regulator shaping the identity and pathological function of inflammatory activated fibroblasts in fibrotic disease contexts. By controlling a core gene network involved in extracellular matrix remodeling, immune cell recruitment, and epithelial integrity, GLIS3 emerges as a promising therapeutic target for fibrotic disorders, including inflammatory bowel disease.

These findings have broad implications beyond the gut, given the conserved transcriptional pathways and cellular interactions mediated by GLIS3. The dependence on cooperative factors such as AP-1 and YAP/TAZ signaling components posits combination-targeting strategies to intercept fibroblast-driven tissue fibrosis and inflammation. Future investigations leveraging single-cell multiomics and in vivo models will be essential to fully unravel the cellular circuitries governed by GLIS3 in diverse fibrotic diseases.

By decoding the GLIS3-dependent transcriptional landscape, this research paves the way toward precision therapies aimed at curbing fibrosis by manipulating fibroblast states. As the global burden of fibrotic diseases escalates, these mechanistic insights into cell-type specific transcriptional control offer new avenues for intervention and biomarker development.

The study is a testament to the power of integrative genomics, functional perturbation screens, and patient-based translational analyses to uncover key drivers of pathological cell states. By bridging in vitro models and human disease cohorts, the authors exemplify the future of molecular medicine directed at complex tissue remodeling processes.

In conclusion, GLIS3 operates as a critical switch in inflammatory activated fibroblasts to promote a fibrotic program through cooperation with other transcriptional regulators. This discovery enriches our understanding of fibroblast biology in chronic inflammation and fibrosis and sets the stage for targeting GLIS3-mediated pathways in clinical fibrotic diseases.

Subject of Research:
GLIS3-dependent transcriptional regulation of inflammatory activated fibroblasts shaping fibrotic tissue remodeling in inflammatory bowel disease.

Article Title:
Bidirectional CRISPR screens decode a GLIS3-dependent fibrotic cell circuit.

Article References:
Pokatayev, V., Jaiswal, A., Shih, A.R. et al. Bidirectional CRISPR screens decode a GLIS3-dependent fibrotic cell circuit. Nature (2026). https://doi.org/10.1038/s41586-025-09907-x

Image Credits: AI Generated

DOI:
https://doi.org/10.1038/s41586-025-09907-x

Keywords:
GLIS3, inflammatory activated fibroblasts, fibrosis, IL11, CRISPR screens, chromatin immunoprecipitation, transcriptional regulation, extracellular matrix remodeling, ulcerative colitis, inflammation, YAP/TAZ signaling, AP-1 complex

Adipose tissue, traditionally viewed merely as a passive reservoir for energy storage, is now recognized as a dynamic organ intricately involved in systemic energy regulation. Within this organ, two primary types of fat cells exist: white adipocytes, which store energy, and brown adipocytes, which dissipate energy as heat through non-shivering thermogenesis. The balance and recruitment of these adipocyte types are essential for metabolic homeostasis, and disruptions can lead to obesity and related disorders.

The study, published in Nature Communications, highlights the pivotal function of c-kit⁺ progenitor cells residing within adipose depots. These progenitors—themselves stem-like cells—display an intrinsic commitment to differentiate into brown adipocytes, suggesting they are integral to maintaining adipose tissue plasticity. This discovery not only underscores their role in tissue remodeling but also identifies a cellular source that might be harnessed to enhance energy expenditure.

Using sophisticated lineage-tracing models combined with single-cell RNA sequencing, the researchers meticulously mapped the fate of c-kit⁺ progenitors in murine adipose tissue. Their findings confirm that these progenitors remain quiescent under basal conditions but become activated and commit to the brown adipocyte lineage in response to environmental stimuli such as cold exposure or β-adrenergic stimulation. This conditional differentiation signifies a responsive mechanism by which the organism remodels its fat depots to meet physiological demands.

Crucially, the study reveals that the recruitment of brown adipocytes from c-kit⁺ progenitors is not merely a developmental remnant but a continuous, adaptive process throughout adulthood. This perpetual turnover supports adipose tissue homeostasis by replenishing the brown adipocyte population and ensuring sustained thermogenic capacity. Such a mechanism could explain the dynamic nature of fat tissues observed in response to metabolic challenges.

The molecular underpinnings of progenitor commitment were dissected, uncovering key signaling pathways and transcriptional networks involved in the fate determination process. The activation of PRDM16 and PGC-1α, master regulators of brown adipocyte identity, was shown to be instrumental in guiding c-kit⁺ progenitors toward the thermogenic lineage. Additionally, extracellular cues such as sympathetic nervous system signaling were highlighted as pivotal triggers facilitating this differentiation cascade.

Beyond differentiation, the study also characterizes the microenvironmental niche of c-kit⁺ progenitors within adipose tissue. The interplay between extracellular matrix components, local cytokine milieu, and vascularization appears to modulate progenitor activation and lineage commitment. This spatial orchestration ensures that progenitors are strategically positioned to respond rapidly to metabolic needs and environmental stressors.

Importantly, the research outlines how the dysregulation of c-kit⁺ progenitor function correlates with impaired adipose tissue remodeling observed in obesity and metabolic syndrome. In experimental models of diet-induced obesity, a marked reduction in c-kit⁺ progenitor activation was linked with diminished brown adipocyte recruitment and compromised thermogenic response. This attenuation could contribute to the pathological expansion of white fat and metabolic derangements.

The identification of c-kit⁺ progenitors as a cellular source for brown adipocytes also holds promising translational potential. Therapeutic strategies aiming to potentiate the proliferation and differentiation of these progenitors could augment brown fat mass and activity, thereby enhancing energy expenditure and countering obesity. Small molecules, biological agents, or gene therapy approaches targeting the regulatory pathways uncovered present exciting future directions.

Furthermore, the study expands the conceptual framework of adipose tissue biology by integrating progenitor cell dynamics into the narrative of metabolic health. It challenges previous paradigms that largely attributed brown adipocyte plasticity to transdifferentiation or pre-existing brown adipocyte precursors alone. This broader view accounts for heterogeneous cellular contributors to adipose remodeling.

From a methodological perspective, the research leveraged cutting-edge imaging and transcriptomic techniques, enabling unprecedented resolution in tracing progenitor fate. This methodological rigor strengthens the robustness of the conclusions and sets a benchmark for future investigations into adipose tissue progenitor biology.

The implications of this work extend beyond obesity, touching on age-related metabolic decline and even systemic inflammatory states tied to adipose tissue dysfunction. Understanding how c-kit⁺ progenitors respond across life stages and disease contexts could inform multi-dimensional therapeutic strategies.

In addition to its metabolic significance, the study prompts intriguing questions about the evolutionary role of adipose tissue remodeling. The ability to dynamically modulate brown adipocyte numbers via progenitor cells may have provided a crucial adaptive advantage in thermoregulation and survival across varying climates and nutritional states.

While the immediate focus is on murine models, the translational relevance to human biology is highly anticipated. Preliminary data suggest the presence of analogous c-kit⁺ progenitors in human adipose depots, warranting further exploration into their role in human metabolic health and disease.

In summary, this seminal work not only unravels previously unrecognized cellular mechanisms underpinning brown adipocyte formation but also highlights the exquisite adaptability of adipose tissue in maintaining organismal energy balance. With metabolic diseases now at epidemic proportions globally, interventions inspired by these cellular insights could revolutionize therapeutic approaches.

As the field moves forward, further research is expected to clarify the signaling networks and niche interactions that regulate c-kit⁺ progenitor behavior, as well as elucidate their interplay with immune cells and other stromal components. This integrative understanding could eventually foster targeted manipulation of adipose tissue to improve metabolic resilience.

The discovery of adipose-resident c-kit⁺ progenitors as key architects of brown adipocyte dynamics marks a paradigm shift in adipose tissue biology. It incites a renewed exploration into fat tissue plasticity, promising breakthroughs in the prevention and treatment of metabolic disorders through harnessing the body’s own cellular toolkit.

Subject of Research: The commitment of adipose-resident c-kit⁺ progenitor cells to differentiation into brown adipocytes and their contribution to the homeostasis and remodeling of adipose tissue.

Article Title: Commitment of adipose-resident c-kit⁺ progenitors to brown adipocytes contributes to adipose tissue homeostasis and remodeling.

Article References:
Chen, Q., Yu, Y., Zhang, R. et al. Commitment of adipose-resident c-kit⁺ progenitors to brown adipocytes contributes to adipose tissue homeostasis and remodeling. Nat Commun 16, 5883 (2025). https://doi.org/10.1038/s41467-025-60754-w

Image Credits: AI Generated